期刊文献+

7-(咪唑-4-烷基酰胺基) -1,3-二氢-1-羧基烷基-5 -苯基-2H-1,4-苯并二氮杂-2-酮——一类新的法呢基蛋白转移酶抑制剂(英文)

7-IMIDAZOLYLALKANAMIDO-1-CARBOXYLALKYLBENZO-DIAZEPINE,A NOVEL SERIES OF FARNESYLTRANSFERASE INHIBITORS
下载PDF
导出
摘要 目的 设计并合成新结构类型的法呢基蛋白转移酶抑制剂。方法 本文结合法呢基蛋白转移酶(FTase)的作用机理和已有FTase抑制剂结构特征 ,设计了一类以苯并二氮杂为分子骨架 ,一端连接有可与锌离子配位结合的咪唑基 ,另一端连接不同长度的末端含羧基的侧链的化合物。此类化合物模拟了FTase配体之一CAAX四肽片段 ,共合成 10个此类新化合物 (6~ 12 ,16~ 18) ,并对其进行体外生物活性测定。结果所有新目的化合物均经1HNMR和HRMS方法确证结构。结论 对FTase抑制活性测定结果表明其中 5个化合物 (9,10 ,16~ 18)有较强的抑制活性。 AIM Design, synthesis and evaluation of a series of 7-imidazolylalkanamido-1-carboxylalkylbenzodiazepine farnesyltransferase (FTase) inhibitors. METHODS and RESULTS Coupling of imidazolylalkylcarboxylic acids and 1-substituted 7-aminobenzodiazepines (5a~5c) yielded 10 new compounds (6~12, 16~18) which were biologically tested against FTase using scintillation proximity assay method. CONCLUSION Five target compounds were found to be potential farnesyltransferase inhibitors.
机构地区 中国医学科学院
出处 《药学学报》 CAS CSCD 北大核心 2002年第7期516-521,共6页 Acta Pharmaceutica Sinica
基金 Chinesenationalgreatbasicdevelopingproject ( 973Project:G19980 5 110 2 )
  • 相关文献

参考文献11

  • 1Cacey PJ, Solski PA, Der CJ, et al.P21 ras is modified by a farnesyl isoprenoid [J]. Proc Natl Acad Sci USA,1989,86(21):8323-8327.
  • 2Stokoe D, MacDonald SG, Cadwallader K, et al. Activation of Ras as a result ofrecruitment to the plasma membrane [J]. Science, 1994,264(5164):1463-1467.
  • 3Ress Y, Goldstein JL, Sebra MC, et al. Inhibition of purified P21rasfarnesyl-protein transferase by Cys-AAX tetrapeptides [J]. Cell, 1990,62(1):81-88.
  • 4Gibbs JB, Oliff A, Kohl NE. Farnesyltransferase inhibitors: ras research yields apotential cancer therapeutic [J]. Cell, 1994,77(2):175-185.
  • 5Daniele ML, Judith SS. Ras farnesyltransferase inhibitors [J]. Drugs Future,1999,24(10):1099-1106.
  • 6Strickland L, Weber PC, Windsor WT, et al. Tricyclic farnesyl protein transferaseinhibitors: crystallographic and calorimetric studies of structure-activity relationships[J]. J Med Chem, 1999,42(12):2125-2144.
  • 7Ding CZ, Hunt JT, Ricca C, et al.3-Imidazolylme-thylaminophenylsufonyltetrahydroquinoline, a novel series offarnesyltransferase inhibitors [J]. Bioorg Med Chem Lett, 2000,10(3):273-275.
  • 8Hunt JT, Lee VG, Leftheris K, et al. Potent, cell active, non-thiol tetrapeptideinhibitors of farnesyltransferase [J]. J Med Chem, 1996,39(2):353-358.
  • 9Arthur AP, Ravi PN. Privileged structure-an update [J]. Annu Rep Med Chem,2000,35:289-298.
  • 10Wang GY, Bergstrom DE. Synthesis of oligonucleotides containingN2-[2-(imidazol-4-yl-acetamido)ethyl]-2′-deoxyguananosine [J]. Tetrahedron Lett,1993,34(42):6725-6728.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部